NASDAQ

vTv Therapeutics Inc. - Class A (VTVT)

♥ 600 Thanks from members

Live price chart, market sentiment, and community perspectives for vTv Therapeutics Inc. - Class A (NASDAQ: VTVT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Vanderbilt UniversityLeadership: Steve Holcombe (CEO)Holder: MacAndrews and ForbesHolder: Vanguard Group Inc.Holder: Geode Capital ManagementTTP399HBI-002Cadisegliatin#VTVT#vTv Therapeutics#Biotech#Diabetes Treatment#Clinical Trials